Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis

References

• Amatu A, Sartore-Bianchi A, Bencardino K, Pizzutilo EG, Tosi F, Siena S. 2019. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol. 30(Suppl_8):viii5–viii15. doi:10.1093/annonc/mdz383.
   PubMedGoogle Scholar
• Cai Y. 2019. Clinical study of compound cantharides capsule combined with chemotherapy in the treatment of advanced non-small cell lung cancer. World Latest Med Info. 74(19):163,226. Chinese.
   Google Scholar
• Cao J, Zhou J, Yang D, Chu J. 2016. Compound taxane combined with chemotherapy and chemotherapy alone A controlled study of advanced non-small cell lung cancer. The Worl Clin Med. 16:100–100,103. Chinese.
   Google Scholar
• Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. 2013. Graphical tools for network meta-analysis in STATA. PLoS One. 8(10):e76654. doi:10.1371/journal.pone.0076654.
   PubMed Web of Science ®Google Scholar
• Chen CR, Zhang CM, Wang JY, Li CX, Yu G. 2011. Clinical efficacy of Zilongjin tablets in combined with docetaxel plus cisplatin in the treatment of intermediate to advanced non-small cell lung cancer. China Prac Med. 6:139–140. Chinese.
   Google Scholar
• Chen JY, Hu XQ, Huang SX, Qin LJ, Wang X. 2016. Effects of cinobufagin capsule combined with GP protocol on immune function in patients with advanced non-small cell lung cancer. Chin Mod Doc. 54:12–15. Chinese.
   Google Scholar
• Chen PF, Wu LC, Shu QJ, et al. 2001. Observation of curative effect of BaiLong tablets combined with chemotherapy in treating non small cell lung cancer (NSCLC). Chin Tradit Pat Med. 03:37–39. Chinese.
   Google Scholar
• Chen Q, Zhang MK, Li XQ, Zhang BB, Wang XL, Song JW. 2018. Huachansu capsules combined with chemotherapy for advanced non-small cell lung cancer observation of curative effect on lung cancer. Mod J Int Tradi Chin Wes Med. 27:984–986. Chinese.
   Google Scholar
• Chen Y. 2020. To investigate the clinical efficacy and safety of Xihuang capsule combined with chemotherapy in the treatment of advanced lung adenocarcinoma. Med Die Heal. 18:12–13. Chinese.
   Google Scholar
• Chi X, Liu LJ, Wang Y, Wang Y. 2021. Effect of compound cantharidin capsules combined with GP chemotherapy in the treatment of advanced non-small cell lung cancer. China Med Her. 18:97–100,103. Chinese.
   Google Scholar
• Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. 2019. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 10(10):ED000142. doi:10.1002/14651858.ED000142.
   PubMedGoogle Scholar
• Du FH, Min XH. 2018. Clinical effect of chemotherapy alone or in combination with Xihuang capsule in treatment of advanced lung adenocarcinoma. J Anhui Univ Chin Med. 37:34–36. Chinese.
   Google Scholar
• Duan QL. 2016. Efficacy of compound cantharides capsule in the treatment of non-small cell lung cancer. Pharmacol Clin Chin Mater Med. 32:191–192. Chinese.
   Google Scholar
• Duma N, Santana-Davila R, Molina JR. 2019. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.013.
   PubMed Web of Science ®Google Scholar
• Fang YY. 2022. To investigate the efficacy of compound cantharides capsule combined with chemotherapy in the treatment of non-small cell lung cancer and its influence on immune function and adverse reactions of chemotherapy. Zhejiang J Trad Chin Med. 57:488–489. Chinese.
   Google Scholar
• Geng CX, Yao J, Wang XL. 2009. Clinical evaluation of Pingxiao capsule combined with chemotherapy for advanced non-small cell lung cancer. China Pharmaceuticals. 21:68–69. Chinese.
   Google Scholar
• Guan W, Li B. 2021. To investigate the effect of Huachansu capsule combined with TP regimen on immune function and quality of life in patients with advanced non-small cell lung cancer. Guizhou Med J. 45:1865–1867. Chinese.
   Google Scholar
• Guo H, Tian F, Jia WJ, Xing XL. 2008. Xihuang pill combined with chemotherapy in the treatment of advanced non-small cell lung cancer clinical observation. J Emer Trad Chin. 17:22–23. Chinese.
   Google Scholar
• Guo YH, Shi HZ, Huang HY, Ma J, Lin QJ. 2002. Clinical observation on the treatment of primary non-small cell lung cancer with Bailong Tablet. Shanghai Med Pharm J. 04:169–170. Chinese.
   Google Scholar
• He SL, Gao YY, Jin XX, Wang Y, Zhang FH, Liu B. 2020. Vinorelbine + cisplatin chemotherapy combined with Xihuang pill observation of curative effect in patients with lung squamous cell carcinoma. Clin J Med Offic. 48:305–306. Chinese.
   Google Scholar
• Huang ML. 2019. To observe the clinical efficacy of cinobufagin combined with GP chemotherapy in the treatment of advanced non-small cell lung cancer. Prac Clin J Int Tradi Chin Wes Med. 19:51–52, 127. Chinese.
   Google Scholar
• Kong YN, Li Y, Xu ZL, Guo Y. 2021. Six common oral Chinese patent medicine combined with platinum-based chemotherapy for NSCLC: Network Meta-analysis. Chin Tradit Herb Drugs. 52(02):507–518. Chinese.
   Google Scholar
• Lan SL, Wu SF, Gao LW, Zuo YF. 2011. 42 cases of non-small cell lung cancer were treated with chemotherapy combined with Pingxiao capsule clinical observation of lung cancer. J Chin Oncol. 17:154–155. Chinese.
   Google Scholar
• Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. 2022. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022 29(1):2130–2161. doi:10.1080/10717544.2022.2094498.
   PubMed Web of Science ®Google Scholar
• Li GS, Ma SP. 2015. Clinical observation of Zilongjin tablets combined with docetaxel and nedpltin in treatment of locally advanced non-small cell lung cancer. Drugs Clinic. 30:1506–1510. Chinese.
   Google Scholar
• Li HF, Wang HB, Dai Y, Yu Q. 2015. Clinical experience of Zilongjin tablet in the treatment of advanced non-small cell lung cancer. Wom Heal Res. 8:30. Chinese.
   Google Scholar
• Li J, Zhu GH, Liu TT, Xu BW, Li J. 2020. Comparative efficacy of Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC: a protocol for systematic review and network meta-analysis. Medicine (Baltimore).). 99(28):e21041. doi:10.1097/MD.0000000000021041.
   PubMed Web of Science ®Google Scholar
• Li J, Yang SY, Jin E, Wang XN, Gao Y. 2017. Clinical efficacy of Hongdoushan capsule combined with chemotherapy on the levels of TSGF, Cyfra21-1,CA125 and CEA for elderly patients with non-small cell lung cancer. Chin J Gene Prac. 15:1524–1526. Chinese.
   Google Scholar
• Li WG, Cui J, Wang JJ, Wang JY. 2015. Clinical observation of bronchial artery infusion chemotherapy combined with Huachansu capsule in the treatment of advanced non-small cell lung cancer. China Pharm. 26:3703–3706. Chinese.
   Google Scholar
• Li XZ. 2020. To investigate the efficacy of Huachansu capsule combined with chemotherapy in patients with advanced non-small cell lung cancer. Prac Clin J Int Tradi Chin Wes Med. 20:47–48. Chinese.
   Google Scholar
• Li YM. 2011. Clinical observation of treating 70 cases of non-small cell lung cancer by KLT capsules in combination with chemotherapy. Clin J Chin Med. 21:8–9. Chinese.
   Google Scholar
• Li ZS. 2019. Huachansu capsule combined with DP chemotherapy in the treatment of advanced non-small cell lung cancer. Henan Med Res. 28:2244–2246. Chinese.
   Google Scholar
• Liang YH, Liu ML, Zhou JL. 2016. To observe the curative effect of compound banao capsule combined with chemotherapy in advanced lung cancer. Shenzhen J Int Trad Chin Wes Med. 26:29–30. Chinese.
   Google Scholar
• Liu BD. 2014. Observe the clinical effect of Huachansu capsules in the treatment of small cell lung cancer. . J Clin Exp Med. 13:1263–1265. Chinese.
   Google Scholar
• Liu TF, Chen XM, Qin XB. 2018. Effect of Xihuang capsules combined with chemotherapy on the untoward and side effect and immune function of patients with non-small cell lung cancer. Sys Med. 3:1–3,6. Chinese.
   Google Scholar
• Liu ZH, Ning TL, Yu RB. 2000. Comparative study of three different combined schemes for advanced non-small cell lung cancer. J Bas Clin Onco. 13:179–180. Chinese.
   Google Scholar
• Long Q, Liu D, Tang WJ. 2013. Clinical observation of compound cantharides capsule combined with chemotherapy after lung cancer surgery. Inn Mong J Tradi Chin Med. 32:10–11. Chinese.
   Google Scholar
• Ma HW, Fang J, Wang SX, Wang DL, Wang T, Wang EW. 2017. Clinical efficacy of Zilongjin tablets combined with chemotherapy in advanced lung cancer. Lab Med Clin. 14:3318–3320. Chinese.
   Google Scholar
• Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. 2022. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 72(5):409–436. doi:10.3322/caac.21731.
   PubMed Web of Science ®Google Scholar
• Ming J, Jiang XJ, Li JR. 2010. Administration of pingxiao tablets before and after GP chemotherapy in patients with intermediate stage or advanced non-small cell lung cancer. J Clin Exp Med. 9:1055–1057. Chinese.
   Google Scholar
• Miu XD, Cao HF, Wang WX. 2014. To observe the short-term efficacy of Huachansu capsule combined with TP regimen in the treatment of advanced non-small cell carcinoma. Chin Fore Med Res. 12:131–133. Chinese.
   Google Scholar
• Mukherjee P, Zhou M, Lee E, Schicht A, Balagurunathan Y, Napel S, Gillies R, Wong S, Thieme A, Leung A, et al. 2020. A shallow convolutional neural network predicts prognosis of lung cancer patients in multi-institutional CT-image data. Nat Mach Intell. 2(5):274–282. doi:10.1038/s42256-020-0173-6.
   PubMedGoogle Scholar
• Nie M, Yao K, Zhu X, Chen N, Xiao N, Wang Y, Peng B, Yao L, Li P, Zhang P, et al. 2021. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nat Commun. 12(1):6479. doi:10.1038/s41467-021-26685-y.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Pu JZ, Lu P, Pan Y. 2017. Effects of Huachansu capsule combined with NP chemotherapy on serum CYFRA21-1, NSE levels and ummune function in advanced NSCLC patients. J Hubei Uni Chin Med. 19:26–29. Chinese.
   Google Scholar
• Ren F, Zhang Y, Wang HP, Cui YX, Wang MY, Chen GG. 2018. The clinical observation on the treatment of mon-small cell lung cancer by compound Taxus capsule combined with cisplatin. Worl Chin Med. 13:1108–1110. Chinese.
   Google Scholar
• Schakel L, Veldhuijzen DS, Crompvoets PI, Bosch JA, Cohen S, van Middendorp H, Joosten SA, Ottenhoff THM, Visser LG, Evers AWM. 2019. Effectiveness of stress-reducing interventions on the response to challenges to the immune system: a meta-analytic review. Psychother Psychosom. 88(5):274–286. doi:10.1159/000501645.
   PubMed Web of Science ®Google Scholar
• Shang RG. 2016. Clinical effects of the Zilongjin tablet plus docetaxel and cisplatin on mid-term or late stage non-small cell lung cancer. Chin J Clin Res. 8:45–46. Chinese.
   Google Scholar
• Shao JH, Huang FM, Fu JW. 2002. Clinical observation of Pingxiao capsule combined with topotecan combined with cisplatin in the treatment of non-small cell lung cancer. J Mod Oncol. 10:229–230. Chinese.
   Google Scholar
• Shen T, Wei YS, Zhang HZ. 2017. Clinical efficacy of Zilongjin tablets in combination with TP regimen for locally advanced non-small cell lung cancer and its effect on T-lymphocyte subsets. Hebei J TCM. 39:1539–1542. Chinese.
   Google Scholar
• Shi W. 2017. To observe the curative effect of Huachansu capsule combined with chemotherapy on advanced non-small cell lung cancer. Guid Chin Med. 15:179–180. Chinese.
   Google Scholar
• Shu JH, Wu LY, Zhou RY. 2002. Clinical observation on the effect of Zilongjin tablets on the reduction of toxicity and efficacy of chemotherapy for middle and late stage lung cancer. Chin J Clin Oncol. 08:65–66. Chinese.
   Google Scholar
• Song Z, Zhou LR, Wang XC, Wang FL. 2019. Clinical observation on compound Banmao capsules combined with oxaliplatin in treatment of non-small cell lung cancer. Drugs Clin. 34:1525–1528. Chinese.
   Google Scholar
• Sun CP, Wang JF, Chen XL, Ye WL, Zhu XL, Liu QX. 2015. Study of Zilongjin tablets combined with chemotherapy on advanced non small cell lung cancer. Chin Arch Tradit Chin Med. 33:1145–1147. Chinese.
   Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Tan XY, Li JC. 2005. Clinical observation of Pingxiao capsule combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Hubei J Tradi Chin Med. 27:29–30. Chinese.
   Google Scholar
• Veroniki AA, Vasiliadis HS, Higgins JP, Salanti G. 2013. Evaluation of inconsistency in networks of interventions. Int J Epidemiol. 42(1):332–345. doi:10.1093/ije/dys222.
   PubMed Web of Science ®Google Scholar
• Wan LX, Wang Y, Wang WL. 2007. Clinical research of Canelim capsule with chemotherapy for advanced non-small cell lung cancer. J Mod Oncol. 15:534–536. Chinese.
   Google Scholar
• Wang GL, Wang JH. 1999. Pingxiao capsule combined with chemotherapy in the treatment of non-small cell lung cancer. Hebei Med. 09:8–10. Chinese.
   Google Scholar
• Wang J, Yan WR. 2008. Study of Zilongjin tablets combined with chemotherapy on non small cell lung cancer in middle or advanced stage. Mod J Integr Tradit Chin West Med. 01:3–4. +7.Chinese.
   Google Scholar
• Wang SM, Li J. 2015. Comparison of the efficacy of Pingxiao capsule and shendan sanjie capsule combined with CP program in the treatment of mon-small cell lung cancer in stage IV. China Pharm. 26:4200–4202. Chinese.
   Google Scholar
• Wang T. 2018. Clinical study on compound Banmao capsules combined with GP regiment in treatment of advanced non-small cell lung cancer. Drugs Clin. 33:3264–3269. Chinese.
   Google Scholar
• Wang X, Cheng ZQ. 2009. Clinical observation of Xihuang pill combined with GP regimen in the treatment of 16 cases of advanced non-small cell lung cancer. China J Tradit Chin Med Pharm. 2:47–48. Chinese.
   Google Scholar
• Wang Y. 2019. Efficacy and safety of Kanglaite capsule combined with GP chemotherapy in patients with advanced non-small cell lung cancer. Chin Fore Med Trea. 33:23–25. Chinese.
   Google Scholar
• Wang ZH. 2009. Analysis of 60 cases of lung cancer in the elderly treated with Zilongjin tablets. Hebei Med J. 31:2156–2157. Chinese.
   Google Scholar
• Wei GH, Xu CM. 2017. Efficacy of different chemotherapy regimens for advanced non-small cell lung cancer. Chin J Clin Oncol. 24:167–169. Chinese.
   Google Scholar
• Wu HB, Zhang J. 2006. Clinical observation on the efficacy and toxicity reduction of Zilongjin tablets in chemotherapy for primary lung cancer. Tianjin Pharm. 06:29–30. Chinese.
   Google Scholar
• Wu LM, Jin L Ma JM, Song CF. 2020. Effect of Huachansu capsule plus etoposide combined with cisplatin on inflammatory factors and serum tumor markers in elderly patients with non-small-cell lung cancer. Hainan Med J. 31:20–22. Chinese.
   Google Scholar
• Wu XF. 2019. Clinical observation on compound cantharidin capsule in the treatment of mon-small cell lung cancer. Chin Med Mod Dis Edu Chin. 17:62–63.
   Google Scholar
• Yan MY, Ye ZR. 2020. Clinical study on compound Banmao capsules assisting chemotherapy for advanced non-small cell lung cancer in senile patients. New J Tradit Chin Med. 52:112–114. Chinese.
   Google Scholar
• Yang HP, Yi B. 2002. To observe the clinical effect of Pingxiao capsule combined with chemotherapy on advanced non-small cell lung cancer. J Mod Oncol. 10:60–61. Chinese.
   Google Scholar
• Yang XC, Tian F, Yu JC. 2017. Clinical study on treatment of primary non-small cell lung cancer with Zilongjin tablets combined with PC chemotherapy. Acta Chin Med. 32:715–717. Chinese.
   Google Scholar
• Yi HH, Chen JH. 2014. Efficacy and economic evaluation of three Chinese patent medicines added to chemotherapy for non-small cell lung cancer. Eval Ana Dru Hos Chin. 14:589–591. Chinese.
   Google Scholar
• Yang J, Zhu X, Yuan P, Liu J, Wang B, Wang G. 2020. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials. Support Care Cancer. 28(8):3571–3579. doi:10.1007/s00520-020-05433-w.
   PubMed Web of Science ®Google Scholar
• Yu FM, Jiang DL. 2018. Clinical study on Zilongjin Tablets combined with GP chemotherapy in treatment of non-small cell lung cancer. Drugs Clinic. 33:1184–1188. Chinese.
   Google Scholar
• Yu TT, Chen F, Chen D, Li J. 2018. Clinical effect and safety of Huachansu capsules combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Chin Mod Med. 25:53–55. Chinese.
   Google Scholar
• Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, et al. 2018. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 6(5):e555–e567. doi:10.1016/S2214-109X(18)30127-X.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Niu YN. 2019. Analysis on the curative effect of Xihuang capsule combined with DP regimen chemotherapy on patients with advanced Non-small cell lung cancer. Chin Med Mod Dis Edu Chin. 17:111–113. Chinese.
   Google Scholar
• Zhang QP, Lou GY, Xu N, Fan Y, Zhong HJ, Lou CJ. 2000. Clinical study of Kanglaite capsules combined with chemotherapy in the treatment of advanced non-small cell lung cancer. Chin J Clin Oncol. 27:77–79. Chinese.
   Google Scholar
• Zhang XF, Wei YQ. 2012. 41 cases of advanced non-small cell lung cancer treated with Zilongjin tablets combined with GP regimen. Shaanxi Med J. 41:875–877. Chinese.
   Google Scholar
• Zhang XW. 2015. To observe the effect of compound taxus capsule combined with TP regimen in the treatment of advanced non-small cell lung cancer. Shaanxi J Tradit Chin Med. 36:833–835. Chinese.
   Google Scholar
• Zhao J, Yuan FH, Zhao ZX. 2011. Pingxiao capsule oral adjuvant chemotherapy in the treatment of middle and late stage observation of curative effect on Lung cancer. Shandong Med J. 51:61. Chinese.
   Google Scholar
• Zhao YJ, Jian GQ, Lv SL. 2007. Effect of pinxiao capsule with chemotherapy in treating non- small cell lung cancer. J Mod Oncol. 09:1323–1324. Chinese.
   Google Scholar
• Zhou XY, Wang PL, Liu XH. 2016. Huachansu capsule and chemotherapy in treatment of patients with advanced lung cancer: a clinical study. Chin Rem Clin. 16:1406–1408. Chinese.
   Google Scholar